Sign In
Buy LIVN
$80.14
-0.91 (-1.12%)
At Close: Jul 31, 2026
LivaNova to Present at the Jefferies Global Healthcare Conference
08:00am, Thursday, 15'th May 2025
LONDON--(BUSINESS WIRE)-- #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will participate in a fireside c
LivaNova PLC (LIVN) Q1 2025 Earnings Call Transcript
02:56am, Sunday, 11'th May 2025
LivaNova PLC (NASDAQ:LIVN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Briana Gotlin – Vice President, Investor Relations Vladimir Makatsaria – Chief Executive Of
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
08:15am, Wednesday, 07'th May 2025
LivaNova (LIVN) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.73 per share a year ago.
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
06:00am, Wednesday, 07'th May 2025
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2025 and updated full-
LONDON--(BUSINESS WIRE)-- #livn--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced 12-month, top-line data from its OSPREY randomized controlled trial (RCT), ev
LivaNova to Announce First-Quarter 2025 Results
08:00am, Wednesday, 26'th Mar 2025
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC will host a conference call to discuss its first-quarter 2025 results on Wed., May 7, 2025, at 1 p.m. London time (8 a.m. Eastern Time).
LivaNova (LIVN) Tops Q4 Earnings Estimates
08:10am, Tuesday, 25'th Feb 2025
LivaNova (LIVN) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.87 per share a year ago.
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
06:00am, Tuesday, 25'th Feb 2025
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.
LivaNova to Present at the Barclays Global Healthcare Conference
09:00am, Friday, 21'st Feb 2025
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
09:00am, Tuesday, 21'st Jan 2025
LONDON--(BUSINESS WIRE)-- #LIVN--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesd
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
09:25am, Monday, 30'th Dec 2024
Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC announced that Brain Stimulation published two pivotal articles chronicling the unipolar cohort data set for the RECOVER clinical study.
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
09:00am, Thursday, 05'th Dec 2024
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place Dec. 6-10 in Los Angeles.
Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know
11:01am, Thursday, 28'th Nov 2024
The mean of analysts' price targets for LivaNova (LIVN) points to a 37.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analyst
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint
08:45am, Monday, 18'th Nov 2024
LIVN's aura6000 significantly increases responder rates. The device also reduces AHI and ODI levels.
